THE LATEST NEWS
ILCSC: Your Front-Row Seat to Lung Cancer Experts & Advances
September 20-21 | Virtual
This year’s International Lung Cancer Survivorship Conference includes on-demand videos on lung cancer basics, global panel discussions on regional care, and six biomarker breakout sessions. New this year are sessions in Mandarin Chinese and Spanish, a special session for the Indian lung cancer community, and a dedicated Young Lung Cancer breakout.
Check out the agenda, packed with sessions from top international experts: Solange Peters, MD, PhD; Jarushka Naidoo, MRCPI; Stephen Liu, MD; Edward Kim, MD, MBA; Jaclyn LoPiccolo, MD, PhD; Benjamin Levy, MD; and Suresh Ramalingam, MD.
Registration is FREE and open now! Don’t miss out on this year’s exciting lineup of star speakers and cutting-edge discussions.
LUNGevity recently announced the expansion of its board - adding four new members: Bob Newman, chairman of ASM Global; Terri Ann DiJulio, three-time lung cancer survivor and advocate; Barry Nelson, retired risk management professional and lung cancer survivor; and Frank Sierawski, general director of Union Pacific Railroad and long-term lung cancer survivor. These additions represent the lived experience of lung cancer, advocacy, health equity, and business leadership and will help accelerate our work to transform lung cancer. The full press release can be viewed on our website.
Pictured below, clockwise from top left: New LUNGevity board members Terri Ann DiJulio, Bob Newman, Barry Nelson, and Frank Sierawski.
Meet Lucas, Fifth Grader and Lung Cancer Fundraiser
You, too, can make a difference!
LUNGevity is thrilled to spotlight Lucas de los Santis, a fifth grader in Florida, who is helping to bring awareness to lung cancer and LUNGevity’s mission. Lucas won a social organization award at his elementary school by writing a compelling submission about lung cancer and the work LUNGevity is doing each day and presenting to his class on the importance of lung cancer awareness. His entry received the most votes, and LUNGevity was the beneficiary of his efforts. Thank you, Lucas!
LUNGevity board member Michael Parisi attended the ceremony and presented Lucas with a special certificate on behalf of the Foundation. We are honored to have met this incredible young man and look forward to seeing his social awareness continue to contribute to society.
Learn how you, like Lucas, can make a difference in your community through our Create Your Own Fundraiser program.
LUNGevity Research Submitted to International Scientific Conference
LUNGevity research is a deep, holistic investment into improving lives for people living with lung cancer. In addition to funding millions of dollars of cutting-edge academic research, we also conduct patient-focused research to shine a light on the true experiences of patients with lung cancer and their families. Our research, backed by sound scientific standards and often published or presented at scientific conferences, lays the groundwork for real change in the lung cancer community.
We are pleased to report that we have submitted the findings of two important new research studies to a major scientific conference – the World Conference on Lung Cancer, to be held in San Diego in September.
- Patient-Reported Doctor Communication and Preference on Treatment Decision Making: Oligometastatic vs Metastatic Lung Cancer
- Unraveling the Impact: Understanding Caregivers in the Lung Cancer Community
To learn more about LUNGevity’s research programs, visit Research | LUNGevity Foundation.
How Do New Drugs Get Approved by the FDA?
Three-part series explains how new treatments are tested and approved
Thousands of researchers are working toward the same goal—to develop new treatments for lung cancer that are safer and more effective. Exciting new treatments emerge and current treatments are put to the test. The action never stops. You can follow along with LUNGevity, staying current with research results as they come in.
Want some help deciphering the research? Join us for our three-part blog series on how new lung cancer treatments get tested and approved. We'll walk you through the clinical trial process and explain the different ways the FDA approves new treatments—so you can understand the research results and make more informed decisions about your treatment plan.
Part 1 is available now and shares how clinical trials test promising new treatments.
LUNGevity Partners with 23andMe to Study Lung Cancer Genetics
The lung cancer community needs you!
LUNGevity has teamed up with 23andMe Holding Co., a leading genetic health and biopharmaceutical company, and 20 lung cancer advocacy organizations to launch an exciting new study on lung cancer genetics.
The study’s goal is simple: to learn more about the genetics of people with lung cancer, better understand who might be at risk, and potentially improve personalized care in the future. Through this collaboration, LUNGevity and other advocacy organizations, lung cancer survivors and advocates, and 23andMe ultimately hope to help advance research toward helping people with lung cancer live longer, better lives.
Help unlock the potential of genetic insights for lung cancer. Learn more and enroll here.
Don’t miss LUNGevity Action Network's next webinar in the Advocacy 101 series, "Patient Advocacy & Self-Advocacy 101," on Monday, August 26, at 3 pm ET. Hear from experts, including Brandon Leonard, Senior Director of Government Affairs, Lauren Humphries, Associate Director of Constituent Engagement, Angela James, Associate Director of Community Engagement & Care Navigation, lung cancer patient and advocate Aurora Lucas, and oncology nurse navigator and patient advocate Kathleen Gamblin as they discuss the importance of self- and patient advocacy. Register to learn how to become an empowered advocate or start from the beginning with the series introduction here.
Sign up for emails from the LUNGevity Action Network to stay updated on news, events, and action alerts, or visit the Take Action page for the latest advocacy campaigns.
Joy Harned, the inspiration for
Team WonderJoy
A decade ago, the world lost a joyful light, Joy Harned, to lung cancer. This summer, in her honor, her biggest fans are taking on an epic challenge as part of Team LUNGevity: a sprint distance triathlon!
Friends Michelle and Allie, both newly 50, are ready to give it their all, while they joke that Michelle’s son, Aidan, is set to swim, bike, and run circles around them.
Allie Harned shares, “Joy would be turning 79 this year, so to honor her memory and fight my own aging process, I'm participating in the Chicago Triathlon to raise money to stop lung cancer—with a goal to raise $1079!”
Learn more about Team LUNGevity and its community of passionate endurance athletes – and how you can join them.
World Lung Cancer Day on August 1 was just the beginning – now we’re gearing up for Lung Cancer Awareness Month beginning with Breathe Deep TOGETHER on October 26!
We are excited to announce the launch of the Lung Cancer Awareness Store, featuring special edition “Anyone With Lungs Can Get Lung Cancer” merchandise and customizable gear. This is more than just apparel; it's a powerful way to spark conversations and raise awareness wherever you go.
Make each piece your own by displaying your team's name, honoring someone you’ve lost, or adding a special message. Every purchase helps fund lifesaving lung cancer research, so start shopping today and join our community in changing public health!
🧦Walk the Talk: Don’t miss out on the limited-edition "Anyone With Lungs Can Get Lung Cancer" socks. Register for Breathe Deep TOGETHER and raise $50 by 8/24 to claim your exclusive pair.
IN CASE YOU MISSED IT
LUNGevity is transforming what it means to be diagnosed and live with lung cancer. Support our mission by making a tax-deductible donation today.
